Clinical Trial Update: A Study of Bexarotene Combined With Radiotherapy in People With Mycosis Fungoides [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the safety of combining Bexarotene with radiotherapy in patients with Mycosis Fungoides, a form of cutaneous T-cell lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous T-cell Lymphoma
• Mycosis Fungoides

Drugs mentioned

• Bexarotene (Bexarotene)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Cutaneous T-cell Lymphoma | Phase 1 | Status: RECRUITING